MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, LYEL had $24,772K increase in cash & cash equivalents over the period. -$28,639K in free cash flow.

Cash Flow Overview

Change in Cash
$24,772K
Free Cash flow
-$28,639K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-38,846 -94,879
Stock-based compensation expense
5,232 11,028
Depreciation and amortization expense
2,566 6,576
Loss on securities purchase agreement put/call
-4,029 -
Net amortization and accretion on marketable securities
1,009 2,890
Loss on property and equipment disposals, net
249 -3,759
Non-cash lease income
995 1,516
Change in fair value of contingent consideration payable
-369 2,075
Impairment of long-lived assets
0 1,443
Change in fair value of success payment liabilities
461 -240
Loss (gain) on marketable equity security
-1 -28
Impairment of other investments
0 0
Prepaid expenses, other current assets and other assets
-420 -4,796
Accounts payable
-779 -1,885
Accrued liabilities and other current liabilities
572 -13,118
Other non-current liabilities
-349 -223
Net cash used in operating activities
-28,577 -89,196
Purchases of property and equipment
62 414
Sales of property and equipment
263 -
Purchases of marketable securities
70,987 165,112
Maturities of marketable securities
74,135 247,639
Net cash provided by investing activities
3,349 82,113
Proceeds from securities purchase agreement equity issuance
50,000 -
Proceeds from exercise of stock options
0 0
Proceeds from employee stock purchase plan
0 184
Taxes paid related to net share settlement of equity awards
0 0
Net cash provided by financing activities
50,000 184
Net increase (decrease) in cash, cash equivalents and restricted cash
24,772 -6,899
Cash and cash equivalents at beginning of period
107,287 -
Cash and cash equivalents at end of period
125,160 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma, Inc. (LYEL)